Abstract
Fecal microbiota transplant (FMT) is currently recommended for recurrent Clostridioides difficile infection. However, it is interesting to acknowledge the potential therapeutic role in other diseases associated with dysbiosis. This review will focus on the current and potential indications of FMT in gastrointestinal diseases, evaluating the available evidence and also exposing the necessary requirements to carry it out.
Translated title of the contribution | Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases |
---|---|
Original language | English |
Pages (from-to) | 223-230 |
Number of pages | 8 |
Journal | Gastroenterologia y Hepatologia |
Volume | 45 |
Issue number | 3 |
DOIs | |
State | Published - 2021 |
Bibliographical note
Copyright © 2021 Elsevier España, S.L.U. All rights reserved.Keywords
- Clostridioides difficile
- Fecal microbiota transplantation
- Gastrointestinal illness
- Microbiome